acrolein has been researched along with Candidiasis, Vulvovaginal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Li, YX; Liu, L; Mao, Y; Peng, X; Qu, S; Tian, J; Wang, Z | 1 |
1 other study(ies) available for acrolein and Candidiasis, Vulvovaginal
Article | Year |
---|---|
Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis.
Topics: Acrolein; Animals; Antifungal Agents; Apoptosis; Calcium; Candida albicans; Candidiasis, Oral; Candidiasis, Vulvovaginal; Cytochromes c; Disease Models, Animal; Female; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mitochondria; Reactive Oxygen Species | 2019 |